DiaMonTech named finalist for HealthTech innovation at Europas Awards 2022


DiaMonTech AG, a young innovative medical technology company, has been selected as a finalist for The Europas Awards 2022. The award, which is in its 10th year and curated by Pathfounder, celebrates innovation in Europe's tech startup ecosystem. Founded by Mike Butcher, Editor-at-Large of TechCrunch, The Europas Awards recognize technological advancements in Europe and draw inspiration from the dynamic tech companies of Silicon Valley.

DiaMonTech's nomination in the HealthTech category highlights the company's mission to improve everyday life with diabetes. "The nomination as a finalist at The Europas Awards underscores our commitment to revolutionize diabetes care through breakthrough non-invasive blood glucose monitoring," said Thorsten Lubinski, co-founder and CEO of DiaMonTech.

The Europas Awards 2022 event brings together industry leaders and gives DiaMonTech the opportunity to showcase its innovation in front of an international jury. DiaMonTech's nomination underpins its position as a pioneer in HealthTech and demonstrates the company's commitment to addressing global health issues through cutting-edge technology.

Company Profile DiaMonTech

The German MedTech company DiaMonTech has developed a novel way to measure biomarkers reagent-free. The first product is a non-invasive blood-sugar monitor that achieves a comparable accuracy as invasive devices. Samsung and other international investors are excited about the technology and invested more than USD 17M  in the company.

Changing the reality of diabetes.

Founded in Berlin in 2015, DiaMonTech develops, produces and markets innovative solutions to measure biomarkers non-invasively. The pioneered and patented photothermal detection method has been researched at a German University over the last 15 years by one of the founders, Prof. Dr.Werner Mäntele. Convinced that this technology has the potential to revolutionize the point of care market, he founded DiaMonTech together with the experienced entrepreneur Thorsten Lubinski. The first product is a blood sugar monitor called D-Pocket that doesn’t require blood sampling, is easy to use and highly precise.

For media inquiries, please contact:

Catalina Plesmann

Stay tuned and get updates.

Notify Me